ALANINE SERIES OF OVINE CORTICOTROPIN RELEASING FACTOR-(OCRF) - A STRUCTURE ACTIVITY RELATIONSHIP STUDY

被引:90
作者
KORNREICH, WD [1 ]
GALYEAN, R [1 ]
HERNANDEZ, JF [1 ]
CRAIG, AG [1 ]
DONALDSON, CJ [1 ]
YAMAMOTO, G [1 ]
RIVIER, C [1 ]
VALE, W [1 ]
RIVIER, J [1 ]
机构
[1] SALK INST BIOL STUDIES,CLAYTON FDN LABS PEPTIDE BIOL,LA JOLLA,CA 92037
关键词
D O I
10.1021/jm00088a024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previous structure-activity relationship studies of CRF have shown that residues 1-4 were not necessary for receptor binding or transduction, that residues 4-8 were important for activation, and that residues 12-41 were mostly responsible for binding. Finally it was proposed that CRF assumed an alpha-helical structure when interacting with its receptor. By systematic substitution of each residue (except residues 1-4) in ovine CRF (oCRF) by Ala, we have investigated the role played by individual side chains in receptor recognition and activation. Out of 33 analogues (synthesized using SPPS on an MBHA resin, purified by RPHPLC and characterized by amino acid and mass spectral analyses), a significant loss of biological potency (< 1% potency of native) was observed for 6 analogues ([Ala6], [Ala8], [Ala10], [Ala12], [Ala14], and [Ala38]); 12 analogues had biological potencies ranging from 1% to 60% and ranked as follows: [Ala35] < [Ala16] < [Ala9] < [Ala19] < [Ala15] < [Ala13] < [Ala7] < [Ala23] < [Ala11] less-than-or-equal-to [Ala21] < [Ala27] less-than-or-equal-to [Ala18]; 8 analogues were found to be equipotent (> 60% and < 150%) ([Ala5], [Ala17], [Ala26], [Ala29], [Ala30], [Ala34], [Ala36], and [Ala37]; and 7 analogues were found to be approximately 2-5 times more potent than native oCRF ([Ala25] = [Ala40] less-than-or-equal-to [Ala39] less-than-or-equal-to [Ala33] < [Ala20] < [Ala22] < [Ala32], in an in vitro pituitary cell culture assay. In summary, the Ala substitutions which showed the greatest loss of potency (< 1% of native oCRF) were those replacing hydrophobic residues while those showing the greatest increase in potency were replacing hydrophilic residues. Of the 22 Ala-containing analogues in the C-terminal half of the molecule, 17 analogues have equal or greater potencies than native oCRF. Substitution of Ala in the N-terminal region (residues 5-19) on the other hand is generally detrimental to biological activity. These results suggest that the side chains of residues 5-19 are very important for receptor binding and activation while, in the C-terminal region, the amino acid side chains may be more responsible for structural conservation than for functional expression.
引用
收藏
页码:1870 / 1876
页数:7
相关论文
共 52 条
[1]   CORTICOTROPIN-RELEASING HORMONE INHIBITION OF GONADOTROPIN-RELEASE AND THE EFFECT OF OPIOID BLOCKADE [J].
BARBARINO, A ;
DEMARINIS, L ;
TOFANI, A ;
DELLACASA, S ;
DAMICO, C ;
MANCINI, A ;
CORSELLO, SM ;
SCIUTO, R ;
BARINI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (03) :523-528
[2]   INTRAVENTRICULAR CORTICOTROPIN-RELEASING FACTOR ENHANCES BEHAVIORAL-EFFECTS OF NOVELTY [J].
BRITTON, DR ;
KOOB, GF ;
RIVIER, J ;
VALE, W .
LIFE SCIENCES, 1982, 31 (04) :363-367
[3]   CORTICOTROPIN RELEASING-FACTOR (CRF) RECEPTOR ANTAGONIST BLOCKS ACTIVATING AND ANXIOGENIC ACTIONS OF CRF IN THE RAT [J].
BRITTON, KT ;
LEE, G ;
VALE, W ;
RIVIER, J ;
KOOB, GF .
BRAIN RESEARCH, 1986, 369 (1-2) :303-306
[4]   CORTICOTROPIN-RELEASING FACTOR RECEPTOR ANTAGONIST - EFFECTS ON THE AUTONOMIC NERVOUS-SYSTEM AND CARDIOVASCULAR FUNCTION [J].
BROWN, MR ;
GRAY, TS ;
FISHER, LA .
REGULATORY PEPTIDES, 1986, 16 (3-4) :321-329
[5]   CORTICOTROPIN-RELEASING FACTOR - ACTIONS ON THE SYMPATHETIC NERVOUS-SYSTEM AND METABOLISM [J].
BROWN, MR ;
FISHER, LA ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J ;
VALE, W .
ENDOCRINOLOGY, 1982, 111 (03) :928-931
[6]   COMPARISON OF THE BIOLOGIC ACTIONS OF CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE [J].
BROWN, MR ;
FISHER, LA ;
SPIESS, J ;
RIVIER, J ;
RIVIER, C ;
VALE, W .
REGULATORY PEPTIDES, 1982, 4 (02) :107-114
[7]   EFFECTS OF CORTICOTROPIN-RELEASING FACTOR, CORTICOTROPIN AND CORTISOL ON GASTROINTESTINAL MOTILITY IN DOGS [J].
BUENO, L ;
FIORAMONTI, J .
PEPTIDES, 1986, 7 (01) :73-77
[8]  
CONLON JM, 1990, PEPTIDES, V11, P891
[9]   ISOLATION AND CHARACTERIZATION OF THE BOVINE HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR [J].
ESCH, F ;
LING, N ;
BOHLEN, P ;
BAIRD, A ;
BENOIT, R ;
GUILLEMIN, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (03) :899-905
[10]   DIFFERENTIAL ANTAGONIST ACTIVITY OF ALPHA-HELICAL CORTICOTROPIN-RELEASING-FACTOR9-41 IN 3 BIOASSAY SYSTEMS [J].
FISHER, L ;
RIVIER, C ;
RIVIER, J ;
BROWN, M .
ENDOCRINOLOGY, 1991, 129 (03) :1312-1316